Treatment of fetal supraventricular tachycardia with flecainide acetate after digoxin failure.

Kofinas, A D; Simon, N V; Sagel, H; Lyttle, E; Smith, N; King, K

Kofinas, A D; Simon, N V; Sagel, H; Lyttle, E; Smith, N; King, K.

Afiliación

Kofinas AD; Department of Obstetrics and Gynecology, York Hospital, PA 17405.

Am J Obstet Gynecol ; 165(3): 630-1, 1991 Sep.

Article en En | MEDLINE | ID: mdl-1909841

RESUMEN

Transplacentally administered digoxin is the drug of choice for the treatment of fetal supraventricular tachycardia. We describe a case of fetal supraventricular tachycardia associated with fetal hydrops that did not respond to digoxin treatment because of a lack of transplacental passage. In contrast, flecainide acetate crossed the placenta and cured the fetus. The clinical implications of this new treatment are discussed.

Asunto(s)

Digoxina/uso terapéutico; Enfermedades Fetales/tratamiento farmacológico; Flecainida/uso terapéutico; Taquicardia Supraventricular/tratamiento farmacológico; Adulto; Femenino; Humanos; Embarazo

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Taquicardia Supraventricular / Flecainida / Digoxina / Enfermedades Fetales Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Am J Obstet Gynecol Año: 1991 Tipo del documento: Article Pais de publicación: Estados Unidos

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links